Alfresa Holdings Corporation Stock
Stocks
2784
JP3126340003
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Delayed
Japan Exchange
20:59:58 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 2,320.00 JPY | +0.35% |
|
+4.10% | -4.50% |
| 10-05 | Healios Completes First 144 Million Yen Culture Supernatant Shipment to JENECEL | MT |
| 06-30 | Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation | CI |
| Market Cap | 406B 2.56B 2.29B 2.13B 1.94B 3.64B 243B 3.71B 25.56B 10B 127B 9.62B 9.42B | P/E 2027 * |
17.5x | P/E 2028 * | 14.7x |
|---|---|---|---|---|---|
| Enterprise Value | 406B 2.56B 2.29B 2.13B 1.94B 3.64B 243B 3.71B 25.56B 10B 127B 9.62B 9.42B | EV / Sales 2027 * |
0.13x | EV / Sales 2028 * | 0.12x |
| Free-Float |
88.98% | Yield 2027 * |
3.07% | Yield 2028 * | 3.45% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 2784 | Delayed | |
OTC Markets
| ARHC.F | Delayed |
| 1 day | +0.41% | ||
| 1 week | +4.10% | ||
| Current month | +2.00% | ||
| 1 month | -0.24% | ||
| 3 months | +0.91% | ||
| 6 months | -5.97% | ||
| Current year | -4.50% |
| 1 week | 2,244 |  | 2,343 |
| 1 month | 2,210 | | 2,410 |
| Current year | 2,106.5 | | 2,685.5 |
| 1 year | 2,106.5 | | 2,685.5 |
| 3 years | 1,897 | | 2,685.5 |
| 5 years | 1,505 | | 2,685.5 |
| 10 years | 1,505 | | 3,350 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ryuji Arakawa
CEO | Chief Executive Officer | 63 | - |
Watase Maiko
ADM | Chief Administrative Officer | - | - |
Toshiki Tanaka
CTO | Chief Tech/Sci/R&D Officer | 63 | 2022-06-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryuji Arakawa
BRD | Director/Board Member | 63 | 2007-05-31 |
Yuji Ueda
BRD | Director/Board Member | 65 | 2025-06-24 |
Yusuke Fukujin
BRD | Director/Board Member | 50 | 2020-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.35% | +4.10% | +8.10% | -0.39% | 2.51B | |
| +2.29% | +6.28% | -19.13% | +15.20% | 178B | |
| +1.29% | +8.77% | +0.12% | +32.64% | 121B | |
| +4.12% | +5.87% | -20.70% | +13.71% | 108B | |
| +0.41% | +3.99% | -44.97% | -9.38% | 75.7B | |
| +1.56% | +6.24% | +6.82% | +80.66% | 64.15B | |
| +1.56% | +1.20% | +14.60% | +66.70% | 53.49B | |
| +2.58% | +6.02% | +3.74% | -25.10% | 51.45B | |
| +3.43% | +6.63% | -14.39% | +28.39% | 41.68B | |
| +5.08% | +3.91% | +34.09% | +15.12% | 31.5B | |
| Average | +2.28% | +5.00% | -3.17% | +21.75% | 72.72B | |
| Weighted average by Cap. | +2.29% | +5.86% | -9.80% | +22.72% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 3,194B 20.2B 18.03B 16.76B 15.24B 28.67B 1,913B 29.19B 201B 78.75B 998B 75.79B 74.19B | 3,289B 20.8B 18.56B 17.25B 15.69B 29.53B 1,970B 30.06B 207B 81.09B 1,028B 78.05B 76.39B |
| Net income | 23.41B 148M 132M 123M 112M 210M 14.02B 214M 1.48B 577M 7.32B 556M 544M | 27.15B 172M 153M 142M 130M 244M 16.26B 248M 1.71B 669M 8.48B 644M 631M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | JP¥2,320.00 | +0.35% | 59,100 |
| 26-10-15 | JP¥2,312.00 | +1.67% | 436,300 |
| 26-10-14 | JP¥2,274.00 | -0.20% | 501,400 |
| 26-10-13 | JP¥2,278.50 | +2.17% | 388,100 |
| 26-10-09 | JP¥2,230.00 | +0.18% | 302,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2784 Stock
Select your edition
All financial news and data tailored to specific country editions
